Morphine reciprocally regulates IL-10 and IL-12 production by monocyte-derived human dendritic cells and enhances T cell activation

Mol Med. 2006 Nov-Dec;12(11-12):284-90. doi: 10.2119/2006–00043.Messmer.

Abstract

We evaluated the effect of morphine on human dendritic cells (DCs). Interestingly, immature DCs were found to express all 3 (mu, kappa, delta) opioid receptors on the cell surface. Chronic morphine treatment (10(-8) to 10(-12) M) during the development of DCs from monocytes augmented LPS-induced upregulation of HLA-DR, CD86, CD80, and CD83 and increased the T cell stimulatory capacity of DCs, which could be inhibited by naloxone, an opioid receptor antagonist. The change in surface phenotype was paralleled by a p38 MAPK-dependent decrease in IL-10 and increase in IL-12 secretion. Our data indicate that morphine exerts an immunostimulatory effect by modulating LPS-induced DC maturation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Dendritic Cells / drug effects
  • Dendritic Cells / immunology*
  • Humans
  • Imidazoles / pharmacology
  • Immunosuppression Therapy
  • Interleukin-10 / biosynthesis*
  • Interleukin-12 / biosynthesis*
  • Lymphocyte Activation / drug effects*
  • Lymphocyte Culture Test, Mixed
  • Monocytes / immunology*
  • Morphine / pharmacology*
  • Opioid-Related Disorders / immunology
  • Pyridines / pharmacology
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology*
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Imidazoles
  • Pyridines
  • Interleukin-10
  • Interleukin-12
  • Morphine
  • p38 Mitogen-Activated Protein Kinases
  • SB 203580